Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

On Oct. 1 and 2, the American Chemical Society held its 21st annual Pharma Leaders Conference, hosted this year at the Merck & Co. campus in Rahway, New Jersey. Leaders in medicinal chemistry from ...

Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory ...

Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent ...

The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of 10 Most Promising Low-Cost Stocks According to Hedge Funds. In this article, we are going to ...

We recently compiled a list of 10 Most Promising Long-Term Stocks According to Hedge Funds. In this article, we will look at ...

The latest trading day saw Merck (MRK) settling at $111.53, representing a +1.68% change from its previous close.

Announces the Appointment of Dr Liz Holmes as Chief Medical Officer Newly established role at further strengthens leadership team and supports global growth Dr Liz Holmes’ rare disease and oncology ...